CAPR9:00 AMCapricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society CongressPresentation / Abstract • Phase 3WMS late-breaking poster presentation Mon, Oct 5, 2026, 9:00 AM EDTGcapricor.com
CAPR8:30 AMCapricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society CongressPresentation / Abstract • Phase 3WMS late-breaking poster session Tue, Sep 29, 2026, 8:30 AM EDTGcapricor.com
CAPR9:25 AMCapricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLAcapricor.com